New Breast Cancer Drug: Promising Results Of PI3K Inhibitor Study Discussed At ASCO A

[News]

A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology (ASCO)...

More... (http://www.medicalnewstoday.com/releases/231505.php)